收藏切换
Cucurbitacin B regulates the resistance of osimertinib by inhibiting cell migration and invasion in non-small cell lung cancer
收藏切换
PDF
Ting WANG1, Qiang QIAN2, Rong CHEN1, Zi-heng HE2, Peng CAO2, 3, Xue-ting CAI1, *, He CUI2, 3, *
Acta Pharmaceutica Sinica | 2025, 60(3) : 731 - 738
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(3): 731-738
Original Articles
Cucurbitacin B regulates the resistance of osimertinib by inhibiting cell migration and invasion in non-small cell lung cancer
Full
Ting WANG1, Qiang QIAN2, Rong CHEN1, Zi-heng HE2, Peng CAO2, 3, Xue-ting CAI1, *, He CUI2, 3, *
Affiliations
  • 1. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing 210028, China
  • 2. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
  • 3. State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing 210023, China
Published: 2025-03-12 doi: 10.16438/j.0513-4870.2024-1074
Outline
收藏切换

Non-small cell lung cancer (NSCLC) is the primary pathological type of lung cancer. Osimertinib, as a third-generation EGFR-TKI (epidermal growth factor receptor-tyrosine kinase inhibitor) targeted drug, effectively prolong the progression-free survival of patients with EGFR-mutated NSCLC. However, drug resistance limits the efficacy of osimertinib. Traditional Chinese medicine can effectively delay the resistance to EGFR-TKIs. In this study, Cucurbitacin B (CuB) was investigated to analyze its pharmacological effects in osimertinib-resistant NSCLC cells through cell viability, migration, and invasion experiments. Public databases were used to screen potential targets of CuB in osimertinib-resistant NSCLC cells, and the interactions between CuB and potential targets were verified through molecular docking, cellular thermal shift assay (CETSA), and microscale thermophoresis (MST). Western blot was used to detect the effects of CuB on downstream pathways of the targets. The results showed that CuB significantly reduced the proliferation activity of osimertinib-resistant NSCLC cells and inhibited the migration and invasion abilities of tumor cells. Mechanistically, CuB inhibited the expression of ERK and AKT molecules by binding to the tyrosine kinase receptor AXL. In summary, CuB exhibits resistance to osimertinib-resistant NSCLC by inhibiting the migration and invasion of resistant cells through regulating the abnormal activation of the AXL-ERK/AKT axis. This study provides a basis for the pre-clinical in vitro efficacy of CuB in the treatment of osimertinib targeted resistance in NSCLC and theoretical support for the development of clinical drug combinations.

non-small cell lung cancer  /  drug resistance  /  osimertinib  /  cucurbitacin B  /  AXL
Ting WANG, Qiang QIAN, Rong CHEN, Zi-heng HE, Peng CAO, Xue-ting CAI, He CUI. Cucurbitacin B regulates the resistance of osimertinib by inhibiting cell migration and invasion in non-small cell lung cancer[J]. Acta Pharmaceutica Sinica, 2025 , 60 (3) : 731 -738 . DOI: 10.16438/j.0513-4870.2024-1074
Year 2025 volume 60 Issue 3
PDF
177
74
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2024-1074
  • Receive Date:2024-10-31
  • Online Date:2025-11-06
  • Published:2025-03-12
Article Data
Affiliations
History
  • Received:2024-10-31
  • Revised:2024-12-30
Funding
Affiliations
    1. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing 210028, China
    2. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
    3. State Key Laboratory on Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing 210023, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2024-1074
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT